ERBB2 and breast cancer: We have shown that in the group of HER2(+) breast cancer patients, there is a statistically significant increase in the amino acids Leu + Ile, Orn, Pro, Tyr Asp, Gly, Phe, and His compared to the HER2(−) group and the controls.